Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Hinyokika Kiyo. Acta Urologica Japonica|September 15, 2016
[A Case of Primary Adrenal Malignant Lymphoma with Inferior Vena Cava Thrombus]Shuhei Hirano, Tetsuo Fujita, Teppei Ooyama, et al.
International Journal of Molecular Sciences|August 26, 2022
Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A ReviewDai Koguchi, Kazumasa Matsumoto, Izuru Shiba, et al.
Cancers|October 23, 2021
Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder CancerSoichiro Shimura, Kazumasa Matsumoto, Yuriko Shimizu, et al.
International Cancer Conference Journal|July 23, 2026
Maintaining complete response to avelumab for lung metastases from native ureteral cancer after kidney transplantation: a case reportYutaka Shiono, Masaomi Ikeda, Soichiro Shimura, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2015
High expression level of preoperative serum Uroplakin III is associated with biologically aggressive bladder cancerHideyasu Tsumura, Kazumasa Matsumoto, Masaomi Ikeda, et al.
International Journal of Molecular Sciences|October 14, 2023
Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical CystectomyHiroki Katsumata, Kazumasa Matsumoto, Kengo Yanagita, et al.
Cancers|May 28, 2022
DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder CancerShuhei Hirano, Kazumasa Matsumoto, Kei Tanaka, et al.
Pageof 3